OFTALMOLOGIA 2 - 2006 BIBLIOGRAFIE SELECTIV| 1. Hall A, Rosenthal A R, Ophthalmology, Mosby International Ltd, 1999 2. Mecocci P, Polidori MC, T<strong>ro</strong>iano L, Cherubini A, Cecchetti R, Pini G, Straatman M, Monti D, Stahl W, Sies H, Franceschi C, Senin U. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radical Bilogy and Medicine 2000; 28 (8): 1243-1248 3. Taylor A, Jacques PF, Epstein E. Relations among aging, antioxidant status, and cataract. Am.J.Clin.Nutr. 1995; 62 suppl : 1439 S - 1447 S 4. Chitkara DK. Cataract formation mechanisms, cap 8.1-8.8, Epidemiology of cataract, Mosby International Ltd, 1999 5. Zetterberg M, Zetterberg H, Palmer M, Rymo L, Blennow K, Tasa G, Ju<strong>ro</strong>nen E, Ve<strong>ro</strong>mann S, Teesalu P, Karlsson J-O, Hoglund K. Apolipop<strong>ro</strong>tein E polymorphism in patients with cataract, British Journal of Ophthalmology 2004; 88:716- 718 6. Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, Papoz L. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. Epidemiol. 2000 Mar 1; 151(5): 497-504 7. Nirmalan PK, Robin AL, Katz J, Tielsch JM, Thulasiraj RD, Krishnadas R, Ramakrishnan R. Risk factors for age related cataract in a rural population of southern India: the Aravind comprehensive eye study, British Journal of Ophthalmology 2004; 88:989-994 8. Ughade SN, Zodpey SP, Khanolkar VA. Risk factors for cataract:a case cont<strong>ro</strong>l study. Indian J Ophthalmol dec 1998; 46(4): 221-7 9. Caulfield LE, West SK, Bar<strong>ro</strong>n Y, Cid-Ruzafa J. Anth<strong>ro</strong>pometric status and cataract:the Salisbury Eye Evaluation p<strong>ro</strong>ject. Am. J. Clin. Nutr. 1999 feb; 69(2): 237-42 10. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma, Investigative Ophthtalmology and Visual Science, 2005; 46: 877-883 11. Mansour Mirsamadi, Issa Nourmohammadi, Manuchehr Imamian, Comparative study of serum Na+and K+ levels in senile cataract patients and normal individuals, International Journal of Medical Sciences 2004;1(3):165-169 12. Shui-Mei L, Shan-Yang L, Mei-Jane L, Rhn-Chu L: Possible mechanism of exacerbating cataract formation in cataract formation in cataractous human lens capsules induced by systemic hypertension or glaucoma. Ophthalmic Res 1997; 29: 83-90 13. Green B, Hertzman C, Kazanjan A, McGrad KM, Sheps SB: Mortality rates after cataract extraction. Epidemiology 1999 may; 10 (3): 288-93 14. Knudsen EB, Baggesen K, Naeser K: Mortality and causes of mortality among cataract-extracted patients. A 10year follow up. Acta Ophtalmol Scand (Denmark)1999 feb; 77(1): 99-102 15. Conway D SG, Buggins P, Hughes E, Lip G, Relationship of interleukin-6 and C-reactive p<strong>ro</strong>tein to the p<strong>ro</strong>th<strong>ro</strong>mbotic state in ch<strong>ro</strong>nic atrial fibrillation, J Am Coll Cardiol, 2004; 43: 2075-2082 16. Hennis A, Wu SY, Barbara N, Leske MC, Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados eye studies, Arch Ophthalmol 2004; 122:525-530 17. Hedge KR, Varma SD. Synergistic effect of glycemic and oxidative stress in cataract formation, Invest Ophthalmol Vis Sci 2004; 45: E-Abstract 1706 18. Stitt AW. The Maillard reaction in eye diseases, Ann. NY Acad.Sci, 2005; 1043: 582-597 19. Shalini VK, Luthra M, Srinivas L, Rao SH, Basti S, Reddy M, Balasubramanian D. Oxidative damage to the eye lens caused by cigarette smoke and fuel smoke condensates, Indian J Biochem Biophys 1994; Aug 31(4):261-6 20. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Buring JE, Hennekens C, Manson Jo Ann E. Smoking Cessation and Risk of Age-Related Cataract in Men, Jama 2000; 284:713-716 21. Avunduk AM, Yardimci S, Avunduk MC, Kurnaz L. Cataractous changes in rat lens following cigarette smoke exposure is prevented by parental defe<strong>ro</strong>xamine therapy, Arch Ophthalmol 1999; vol17:1368-1372 22. Nicholl ID, Stitt AW, Moore JE, Ritchie AY, Archer DB, Bucala R. Increased levels of advanced glycation endp<strong>ro</strong>ducts in the lenses and blood vessels of cigarette smokers, Mol Med (USA) 1998; 4(9):594-601 23. Trevithick CC, Vinson JA, Caulfeid J, Rahman F, Derksen T, Bocksch L, Hong S, Stefan A, Teufel K, Wu N, Hirst M, Trevithick JR. Is ethanol an important antioxidant in alcoholic beverages associated with risk reduction of cataract and athe<strong>ro</strong>scle<strong>ro</strong>sis?, Redox Report 1999; vol.4, no3:89-93 24. Harding JJ, van Heyningen R. Drugs, including alcohol, that act as risk factors for cataract, and possible p<strong>ro</strong>tection against cataract by aspirin-like analgesics and cyclopenthiazide, British Journal of Ophthalmology 1988; 72:809-814 25. Zeng J, Borchman D, Paterson CA. Acute effect of ethanol on lens cation homeostasis, Alcohol 1998 oct; 16(3):189-93 26. van den Brule J, Degueldre F, Galand A. Les cataractes d'origine medicamenteuse, Rev Med Liege 1998; 53,12:766-769 8
OFTALMOLOGIA 2 - 2006 27. Dinning WJ. Ste<strong>ro</strong>ids and eye- indications and complications, Postgrad Med J 1976, oct; 52: 612-634 28. Prescosolido N, Miccheli A, Manetti C, Iannetti GD, Feher J, Cavalloti C. Metabolic changes in rabbit lens induced by treatment with dexamethasone, Ophthalmic Res 1994; 33:68-74 29. Garbe E, Suissa S, LeLorier J. Association of Inhaled Corticoste<strong>ro</strong>id Use With Cataract Extraction in Elderly Patients, Jama 1998; 280:539-543 30. Garbe E, Suissa S, LeLorier J. Exposure to allopurinol and the risk of cataract extraction in eldery patients, Arch Ophthalmol 1998 dec; 116 (12): 1652-1656 31. Teshima R, Taura T, Okamura R. Effect of pregnancy on development of galactose-induced cataract in rat, Japanese Journal of Ophthalmology 1993; 37 32. Scharf J, Azzam N, Schapira D, Dovrat A, Gershon D, Silbermann M. Influence of 17- -estradiol and p<strong>ro</strong>geste<strong>ro</strong>ne on rat ocular lens, Ophthalmic Res 1995; 27:197-201 33. Woolard ACS, Bascal ZA, Armst<strong>ro</strong>ng GR, Wolff SP. Diabetes 1990; vol39, no90:1347-1352 34. Plater ML, Goode D, Crabbe MJC. Ibup<strong>ro</strong>fen p<strong>ro</strong>tects alpha-crystallin against posttranslational modification by preventing p<strong>ro</strong>tein c<strong>ro</strong>ss-linking, Ophthalmic Res 1997; 29: 421-428 35. Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buri JE, Hennekens CA. Low-dose aspirin and the risk of cataract and subtypes in a randomized trial of US physicians, Ophtalmic Epidemiol, sep 1998; 5(3):133-142 36. Gupta SK, Joshi S. Role of nap<strong>ro</strong>xen as antioxidant in selenit cataract, Ophtalm Res 1999; 26,4: 226-31 37. Varma SD, Devamanoharan PS. Oxidative Denaturation of lens p<strong>ro</strong>tein: prevention by pyruvate, Ophthalmic Res 1995; 27:18-22 9
Change language